Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: A phase II study

被引：0
|
作者：
Orditura, M.
Aurilio, G.
Galizia, G.
Carlomagno, C.
Lieto, E.
Vecchione, L.
Martinelli, E.
De Placido, S.
Catalano, G.
Ciardiello, F.
De Vita, F.
机构：
[1] Univ Naples, Cattedra Oncol Med, Naples, Italy
[2] Univ Naples, Cattedra Chirurg Gen & Epatobiliare, Naples, Italy
[3] Univ Naples Federico II, Dipartimento Endocrinol & Oncol Mol & Clin, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI52 / XI52
页数：1
相关论文
共 50 条
  • [41] Weekly paclitaxel in the treatment of advanced or metastatic breast cancer previously treated or not treated with docetaxel: A phase II study
    Nishimura, R
    Ogawa, T
    Kato, M
    Tanaka, M
    Hamada, Y
    Shibata, T
    Ishikawa, E
    Koga, T
    Mitsuyama, S
    Tamura, K
    CHEMOTHERAPY, 2005, 51 (2-3) : 126 - 131
  • [42] Phase II trial of weekly docetaxel/fluorouracil/cisplatin in patients with advanced gastric cancer: Preliminary results
    Evangelista, W.
    Racca, P.
    Fanchini, L.
    Ritorto, G.
    Ciorba, A.
    Facilissimo, I
    Napoletano, R.
    Fusco, V
    Alabiso, O.
    ANNALS OF ONCOLOGY, 2008, 19 : 48 - 48
  • [43] A phase II study of weekly paclitaxel and doxifluridine (an intermediate metabolite of capecitabine) combination chemotherapy for advanced/recurrent gastric cancer.
    Takeyoshi, I
    Makita, F
    Tanahashi, Y
    Iwazaki, S
    Nakamura, S
    Ogawa, T
    Ishikawa, H
    Ohya, T
    Kawate, S
    Morishita, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 328S - 328S
  • [44] PRELIMINARY RESULTS OF A MULTICENTER PHASE II STUDY OF NEO-ADJUVANT DOCETAXEL AND CAPECITABINE IN THE TREATMENT OF GASTRIC CANCER IN SINGAPORE
    Lopes, G.
    So, J.
    Wong, W.
    Tan, D.
    Lim, K.
    Ong, S.
    Foo, K.
    Poon, D.
    Mesenas, S.
    Chang, A.
    ANNALS OF ONCOLOGY, 2009, 20 : 86 - 86
  • [45] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Lu, Yen-Shen
    Chen, Dar-Ren
    Tseng, Ling-Min
    Yeh, Dah-Cherng
    Chen, Shou-Tung
    Hsieh, Chia-Ming
    Wang, Hwei-Chung
    Yeh, Hsien-Tang
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1257 - 1263
  • [46] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Yen-Shen Lu
    Dar-Ren Chen
    Ling-Min Tseng
    Dah-Cherng Yeh
    Shou-Tung Chen
    Chia-Ming Hsieh
    Hwei-Chung Wang
    Hsien-Tang Yeh
    Sung-Hsin Kuo
    Chiun-Sheng Huang
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1257 - 1263
  • [47] Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer
    Kusama, Mikihiro
    Nomizu, Tadashi
    Aogi, Kenjiro
    Yoshimoto, Masataka
    Horikoshi, Noboru
    Tabei, Toshio
    Noguchi, Shinzaburo
    Miura, Shigeto
    Yoshimura, Norio
    Kimura, Morihiko
    Toyama, Kazushige
    Shin, Eisei
    BREAST CANCER, 2010, 17 (04) : 233 - 240
  • [48] Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer
    Mikihiro Kusama
    Tadashi Nomizu
    Kenjiro Aogi
    Masataka Yoshimoto
    Noboru Horikoshi
    Toshio Tabei
    Shinzaburo Noguchi
    Shigeto Miura
    Norio Yoshimura
    Morihiko Kimura
    Kazushige Toyama
    Eisei Shin
    Breast Cancer, 2010, 17 : 233 - 240
  • [49] Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
    Li, Wenhua
    Xu, Jianming
    Shen, Lin
    Liu, Tianshu
    Guo, Weijian
    Zhang, Wen
    Chen, Zhiyu
    Zhu, Xiaodong
    Li, Jin
    BMC CANCER, 2014, 14
  • [50] Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
    Wenhua Li
    Jianming Xu
    Lin Shen
    Tianshu Liu
    Weijian Guo
    Wen Zhang
    Zhiyu Chen
    Xiaodong Zhu
    Jin Li
    BMC Cancer, 14
12345